1 – 9 of 9
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
2024) In BJU International(
- Contribution to journal › Article
- 2023
-
Mark
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
(
- Contribution to journal › Article
-
Mark
Implementation of the measure of case discussion complexity to guide selection of prostate cancer patients for multidisciplinary team meetings
(
- Contribution to journal › Article
- 2022
-
Mark
Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors
(
- Contribution to journal › Article
-
Mark
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy - The PROPER 1 trial
(
- Contribution to journal › Article
-
Mark
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
(
- Contribution to journal › Article
- 2020
-
Mark
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour : A Population-based Study from the Swedish Norwegian Testicular Cancer Group
(
- Contribution to journal › Article
- 2011
-
Mark
Risk of Birth Abnormalities in the Offspring of Men With a History of Cancer: A Cohort Study Using Danish and Swedish National Registries.
(
- Contribution to journal › Article
-
Mark
Population-Based Study of Treatment Guided by Tumor Marker Decline in Patients With Metastatic Nonseminomatous Germ Cell Tumor: A Report From the Swedish-Norwegian Testicular Cancer Group.
(
- Contribution to journal › Article